{"id":"W2589233229","doi":"10.1200/jco.2012.30.15_suppl.tps658","title":"HALT MBC: HER2 suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (LPT112515).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Lapatinib; Trastuzumab; Metastatic breast cancer; Internal medicine; Discontinuation; Oncology; Clinical endpoint; Breast cancer; Chemotherapy; Blockade; Cancer; Adverse effect; Clinical trial; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005587118,0.0008350987,0.001121782,0.0004044838,0.0002458331,0.0005194772,0.0008007731,0.0007465812,0.003177192],"category_scores_gemma":[0.0003534846,0.0003058745,0.0006306866,0.0003428482,0.0005607036,0.0005890387,0.0003907763,0.002169976,0.0006581095],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005773178,"about_ca_system_score_gemma":0.000907983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000871626,"about_ca_topic_score_gemma":0.00224403,"domain_scores_codex":[0.9998063,0.00005031595,0.00001195896,0.00003438145,0.00003139762,0.00006575826],"domain_scores_gemma":[0.9998249,0.00002400499,0.00004098993,0.00001465874,0.000006784428,0.0000886311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3630285,0.07883252,0.01283208,0.001369028,0.0009937733,0.00119837,0.0003037661,0.00402893,0.2589943,0.0007682266,0.006659656,0.2709908],"study_design_scores_gemma":[0.2067505,0.709809,0.02667231,0.00006966165,0.0005472263,0.001895903,0.00007749486,0.002156163,0.04367334,0.0002283203,0.008068503,0.00005154812],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963925,0.001116186,0.0001717797,0.0002726378,0.00006305442,0.0004137346,0.0003650426,0.00008204357,0.001123043],"genre_scores_gemma":[0.9945318,0.001024856,0.0006376466,0.0002792624,0.00007647302,0.000612015,0.00117693,0.00001392648,0.001647097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003177192,"threshold_uncertainty_score":0.01062876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1545185930237691,"score_gpt":0.5411181389432805,"score_spread":0.3865995459195114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}